Warning letter
Kentron Health Care, Inc.: warning letter of Mar 26, 2012
FDA warning letter 268177 · New Orleans District Office
Key facts
| Reference number | 268177 |
|---|---|
| Company | Kentron Health Care, Inc. |
| Subject | Medical Device Reporting/Misbranded |
| Issue date | Mar 26, 2012 |
| Posted date | Mar 26, 2012 |
| Issuing office | New Orleans District Office |
| Product type | Devices |
| CFR sections cited | 803, 803.3, 803.17(a), 803.20(c)(1), 820, 803.50(b), 803.50(b)(3) |
| Inspection city | Springfield |
| Inspection ZIP | 37172 |
| Inspection start date | Oct 5, 2011 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: